Skip to main content

HIV/AIDS and cannabis in Alaska

The state explicitly lists this condition under its medical cannabis program. A certifying physician can pursue state registration for a patient with this diagnosis under the program rules.

Listed qualifying condition
✓ Yes
LEGAL
Up to 1 oz usable canna…
POSSESSION
$25/yr
STATE FEE
14–45 d
TIMELINE
Listed qualifying condition. The state explicitly lists this condition under its medical cannabis program. A certifying physician can pursue state registration for a patient with this diagnosis under the program rules.

Alaska statute and program

The Alaska Medical Marijuana Registry is the operating authority for Alaska patient certification. The authoritative legal text is: Alaska Statutes Title 17 Chapter 38: Regulation of Marijuana. The program portal is at Alaska Medical Marijuana Registry.

What the evidence says about cannabis and HIV/AIDS

HIV (human immunodeficiency virus) is a retrovirus that targets the immune system. Untreated, it progresses to AIDS (acquired immune deficiency syndrome), defined by severely depleted CD4 T-cell counts and opportunistic infections. Modern antiretroviral therapy has transformed HIV into a chronic manageable condition for most patients with consistent access to treatment.

For the full evidence base, including the NASEM tier, randomized trial summaries, and symptom-domain breakdown, read the mmjnow HIV/AIDS page.

How to qualify in Alaska

The Alaska Medical Marijuana Registry requires the following registration steps for a HIV/AIDS patient (or any qualifying diagnosis):

  1. Get a Written Physician Statement from an Alaska-licensed physician. Under AS 17.37 (Alaska Medical Use of Marijuana Act, Ballot Measure 8 of 1998), any Alaska-licensed physician (MD or DO) may complete the Written Physician Statement attesting that the patient has been diagnosed with a debilitating medical condition (cancer, glaucoma, HIV/AIDS, MS, severe and chronic pain, severe nausea, seizures, severe and persistent muscle spasms, or cachexia) and that the patient may benefit from medical use of marijuana.
  2. Apply by mail to the Alaska Medical Marijuana Registry. The patient mails the completed Application for Registry Identification Card, the Written Physician Statement, a copy of an Alaska driver license or state ID, and the registration fee to the Alaska Department of Health, Division of Public Health, Bureau of Vital Statistics. Alaska does not currently offer an online application option.
  3. Pay the $25 state registration fee. The annual Alaska medical marijuana registry identification card fee is $25 ($20 for renewal). Designated caregiver registration is an additional $25 and requires a state criminal background check; caregivers must be Alaska residents and must not have a prior felony conviction.
  4. Receive the card and possess up to 1 ounce. Alaska medical marijuana registry cards are typically issued within 30 days of complete application. Registered patients may possess up to 1 ounce of usable cannabis and cultivate up to 6 plants (with no more than 3 mature) for personal medical use. Alaska does not operate a state-licensed medical dispensary system separate from adult-use retail. Adult-use retail is legal statewide for adults 21+. Alaska does not honor out-of-state medical cards.
State registration fee
$25
Physician visit (typical)
$150–$300
Certification to card
14–45 days
Out-of-state patients
Not eligible
Minors
Eligible with caregiver

For full Alaska registration steps, fees, and reciprocity rules, see the Alaska cannabis-laws page.

ICD-10 code

A certifying physician documenting HIV/AIDS for the Alaska medical cannabis program will typically record ICD-10 B20 or SNOMED-CT 86406008 in the patient's record. The state registry does not itself collect ICD-10 codes in most programs, but the physician's chart is the audit trail if the certification is later reviewed.

Frequently asked questions

Does Alaska list HIV/AIDS as a qualifying condition for medical cannabis?

Yes. Alaska explicitly lists HIV/AIDS as a qualifying condition under Alaska Medical Marijuana Registry. A patient with a documented HIV/AIDS diagnosis can pursue state-program certification with a physician registered in the state. The qualifying-condition list is published by the state at https://health.alaska.gov/dph/VitalStats/Pages/marijuana.aspx and may change as regulators add, remove, or refine entries. Inclusion on the list does not guarantee certification — a physician still has to evaluate the patient and decide that medical cannabis is appropriate for that specific case under Alaska rules.

How do I get a Alaska medical marijuana card for HIV/AIDS?

Step one is finding a physician licensed in Alaska who is registered with Alaska Medical Marijuana Registry and willing to evaluate HIV/AIDS cases. Step two is collecting your records (diagnosis documentation, treatment history, and the ICD-10 code your physician will use) and bringing them to the certification visit. Step three is the physician's certification through the state registry, followed by the patient registration application, state fee, and waiting period before the card is issued. Alaska does not honor out-of-state cards, so the certification process has to originate inside the state. Verify the patient minimum age with the state program before applying. The authoritative source for the current process is the Alaska Medical Marijuana Registry site at https://health.alaska.gov/dph/VitalStats/Pages/marijuana.aspx; the state updates fees, forms, and physician registration rules periodically.

What does the evidence say about cannabis for HIV/AIDS?

For HIV/AIDS, evidence is described as moderate (supportive controlled studies exist but the picture is mixed). The mmjnow condition page for HIV/AIDS lays out the current evidence base, including the citations underlying that evidence tier — typically the National Academies of Sciences, Engineering, and Medicine consensus reports, federal agency guidance, and peer-reviewed reviews. Evidence quality is independent of state law: a state can list a condition for which evidence is limited, and a state can decline to list a condition for which evidence is strong. Patients deciding whether to pursue medical cannabis for HIV/AIDS should review the underlying evidence (linked on the condition page) and discuss expected benefit, dosing, and risk with a clinician familiar with both HIV/AIDS and cannabinoid pharmacology. Cannabis is not a substitute for evidence-based first-line treatments for HIV/AIDS; the evidence position above describes whether trial data supports its use, not whether it should replace standard care.

Sources

  1. Alaska Statutes Title 17 Chapter 38: Regulation of Marijuanaaccessed May 16, 2026
  2. Alaska Marijuana Control Board (Alcohol and Marijuana Control Office)accessed May 16, 2026
  3. Alaska Department of Health: Medical Marijuana Registryaccessed May 16, 2026
  4. Wikipedia: Cannabis in Alaskaaccessed May 16, 2026
  5. NASEM: The Health Effects of Cannabis and Cannabinoids (2017)accessed May 15, 2026
  6. NIH NCCIH: Cannabis (Marijuana) and Cannabinoidsaccessed May 15, 2026